Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06815367 · ClinicalTrials.gov registry record · NA
Pneumatic Compression vs Blood Flow Restriction for Muscle Recovery
A NA study of Delayed Onset Muscle Soreness, sponsored by University of Southern California.
- Recruiting
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT06815367: Recruiting NA study of Delayed Onset Muscle Soreness, sponsored by University of Southern California.
NCT06815367 is a NA study of Delayed Onset Muscle Soreness that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 33 participants, below the 40-participant average among 3 other Delayed Onset Muscle Soreness trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06815367, a NA study of Delayed Onset Muscle Soreness, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
Both BFR and intermittent pneumatic compression are purported to decrease symptoms associated with exercise induced muscle damage (EIMD) that cause delayed onset muscle soreness (DOMS). Blood flow restriction relies on applying pressurized cuffs to the most proximal portion of the limb. Another form of recovery often relied upon is pneumatic compression. The mechanism by which pneumatic compression works is similar to that of a massage, whereby the device progressively increases the pressure on a portion of the limb before releasing and moving further up the limb.The purpose of this study is determine whether BFR or pneumatic compression can be used to decreased DOMS which may indicate enhanced recovery.
Primary Outcome
Participants will be asked to complete three consecutive counter movement jumps with hands on hips. The CMJ will be used as an indirect measure of muscle function.
Conditions Studied
Interventions
- DEVICE Pneumatic Compression
- DEVICE Blood Flow Restriction
Study Locations (1)
California
- University of Southern California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2024-01-15 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
What NCT06815367 shows while recruiting
NCT06815367 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 40-participant average among 3 other Delayed Onset Muscle Soreness trials with a reported enrollment target (17% lower).
The record links to 1 condition, with Delayed Onset Muscle Soreness appearing as the primary indexed condition, and to 2 interventions - of which Pneumatic Compression is the first listed.
NCT06815367 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06815367 about?
NCT06815367 is a clinical study titled "Pneumatic Compression vs Blood Flow Restriction for Muscle Recovery". Both BFR and intermittent pneumatic compression are purported to decrease symptoms associated with exercise induced muscle damage (EIMD) that cause delayed onset muscle soreness (DOMS). Blood flow restriction relies on applying pressurized cuffs to the most proximal portion of the limb. Another form...
What is the current status of trial NCT06815367?
This trial is currently recruiting. It is a NA study. The enrollment target is 33 participants. The study started on 2024-01-15. Estimated completion is 2025-12-01.
What conditions does trial NCT06815367 study?
This clinical trial studies the following conditions: Delayed Onset Muscle Soreness.
What interventions are being tested in trial NCT06815367?
The interventions under investigation include: Pneumatic Compression (DEVICE), Blood Flow Restriction (DEVICE).
Who is sponsoring clinical trial NCT06815367?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06815367 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delayed Onset Muscle Soreness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Kinesio Tape on Delayed Onset Muscle Soreness
RECRUITING · NA
-
A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness
COMPLETED · Phase 4
-
An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI